Adynovate® (antihemophilic factor (Recombinant), PEGylated)
for Hemophilia

Adynovate is a recombinant, PEGylated antihemophilic factor used to treat and prevent bleeding episodes in adults and children with hemophilia A. It replaces the missing clotting factor VIII in the blood, helping to promote normal blood clotting. Adynovate is also administered before surgery to prevent excessive bleeding and can help prevent joint damage in children with hemophilia A who have no prior joint damage.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Hemophilia